Patricia Carr

Patricia Carr

Senior Vice President and CAO (Former Interim Principal Financial Officer)atJazz Pharmaceuticals· In proxies 2023–2024

Pay in FY2024+4% from the year before · Jazz Pharmaceuticals stock +0.1% the same year

Patricia Carr was paid $1.5M in FY2024 (Dec), up 4%. Jazz Pharmaceuticals stock rose 0.1% that year.

Pay$100 in the stock at the end of FY22 → $77
Pay is from the Summary Compensation Table of each Jazz Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Jazz PharmaceuticalsPublic company · 3 yr
    • Senior Vice President and CAO (Former Interim Principal Financial Officer)2023 – Present · 3 yrStock in role +29%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?